Health Shield GmbH Germany is a development and investment company active in the field of non-communicable and communicable diseases, developing formulations for the treatment of early-onset and advanced autoimmune, inflammatory and allergic diseases.

We support and lead multidisciplinary teams in research areas such as intestinal bacteria/ synbiotics,
Mast cell activation, intestinal permeability, which often leads to inflammatory diseases, severe food allergies and bacterial co-infections.
In addition, our teams are developing a phyto-pharmaceutical suspension for the treatment of Covid 19 and post-Covid symptoms, which after clinical testing can now also be purchased directly from our subsidiary in India.